Incyte Corporation Price Today
Incyte Corporation
INCY
Healthcare
$14.20B
💰
Market Cap
44.5
💸
Price to Earnings
$1.4
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
6 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
INCY Price Forecast Target
63.6 👉 114.0 +79%
INCY EPS Forecast
1.4 👉 4.6 +221%
Financials
Profit Margin
10 %
Revenue Growth
4.7 %
Dividend
$ 0
Held Percent
1.4% - Insiders
99.4% - Institutions
-0.8% - Public
Major Fund Holders
-
💰 Baker Brothers Advisors, LLC $2.6B
-
💰 Vanguard Group Inc $1.6B
-
💰 Blackrock Inc. $1.5B
-
💰 Dodge & Cox Inc $1.4B
-
💰 Royal Bank of Canada $915.5M
Stock Ideas
David Shaw Portfolio
David Shaw is a renowned computer scientist, technological pioneer, and founder of D.E. Shaw Group, one of the earliest quantitative hedge funds. Shaw pioneered the use of algorithmic and computational modeling in institutional investing. While litt…
Bruce Berkowitz Portfolio
Bruce Berkowitz, the esteemed founder of Fairholme, has established himself as a prominent figure in the investment world with his exceptional portfolio strategy. Since its inception in 1999, Fairholme has grown into a formidable $19 billion mutual …
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.📮FAQ
Some Frequently Asked Questions.
The Incyte Corporation industry is Biotechnology
The Incyte Corporation sector is Healthcare
The Incyte Corporation forecasted predicted Price to Earnings PE ratio is 13.9
The Incyte Corporation Price to Earnings PE ratio is 44.5
The Market Capitalization of Incyte Corporation is $14.20B
There are total of 186324437 float shares with 99.4% held by Institutions and 1.4% held by insiders
The MIncyte Corporation forecasted Earnings per Share EPS is $4.6
The Incyte Corporation Earnings per Share EPS is 1.4
The Incyte Corporation company has $1593729000 gross profits with 10 profit margins
The Incyte Corporation Earnings Growth is 0.25% with 0.261% quarterly earnings growth
The Incyte Corporation Revenue is $3513285888 with 0.047 revenue growth
The price target for Incyte Corporation stock is $114.0 for the high target and $65.0 for the low target
The consensus analyst recommendations for Incyte Corporation is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Incyte Corporation is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 6
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Incyte Corporation is 0.7
The dividend of Incyte Corporation is $0
The dividend yield of Incyte Corporation is 0%
The biggest institutional and mutual fund holders of Incyte Corporation stock are
- Baker Brothers Advisors, LLC
- Vanguard Group Inc
- Blackrock Inc.
- Dodge & Cox Inc
The Incyte Corporation ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0